image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
392007e6842061606b0995780950182e89ec276f0bf9bfc18e9f25667c5bca1a.png | simple | <table><tr><td>Sample</td><td>mPEG-acid (g)</td><td>Chitosan (g)</td><td>EDC (g)</td><td>NHS (g)</td></tr><tr><td>mPEG-g5-Chitosan</td><td>0.43</td><td>0.50</td><td>0.20</td><td>0.12</td></tr><tr><td>mPEG-g6-Chitosan</td><td>0.43</td><td>0.45</td><td>0.20</td><td>0.12</td></tr><tr><td>mPEG-g7-Chitosan</td><td>0.43</td>... |
0f01f1e06d143c61d125ae4737c2473748c59aa37638c32221b076aa55e06dfe.png | complex | <table><tr><td> </td><td>N</td><td>%</td></tr><tr><td>Total number of patients</td><td>14</td><td> </td></tr><tr><td>Age</td><td> </td><td> </td></tr><tr><td>Median (Range)</td><td colspan="2">69.5 (38–88)</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td>Male</td><td>9</td><td>64</td></tr><tr><td>Fema... |
aa20c2f8d13195d90d1292f9b5ca58f8baeec29ebbed52940131954549c6ac44.png | simple | <table><tr><td>Protein</td><td>Gene symbol</td><td>Gene ID</td><td>Sequence 5′- 3′ F</td><td>Sequence 5′- 3′ R</td></tr><tr><td>Lipocalin2</td><td>Lcn2</td><td>16819</td><td>ATATGCACAGGTATCCTCAG</td><td>GAAACGTTCCTTCAGTTCAG</td></tr><tr><td>CD163</td><td>Cd163</td><td>93671</td><td>AGTCTGCTCACGA... |
a591ee38fd010de21fe86d7ba988dc4b29295b71f498ea75e349192e4423e2b6.png | simple | <table><tr><td>SNP marker</td><td>Position (bp)*</td><td>Location</td><td>SNP†</td><td>MAF‡</td><td><i>P</i> value§</td><td>SLI association¶</td></tr><tr><td>rs7806058</td><td>146007792</td><td>Intron 1</td><td>A/G</td><td>0.35</td><td>ns</td><td>−</td></tr><tr><td>rs6946112</td><td>14605921... |
46f3002c47a840826f71d7f2391a1af129317055af1c0d3bd0f987941c2f81f1.png | simple | <table><tr><td>CHR</td><td>GENE</td><td>SNP</td><td>OR</td><td>L95</td><td>U95</td><td>P</td></tr><tr><td>19</td><td><i>APOE</i></td><td>rs157580</td><td>0.51</td><td>0.45</td><td>0.59</td><td><i>3.30E-21</i></td></tr><tr><td>5</td><td><i>HMGCR</i></td><td>rs3846662</td><td>1.16</td><td>1.02</td><td>1.32</td><td><i>0.0... |
3fd203c97aeb26d6667668b97b0fc410bdc68a472f79120797211f7ce87c8f75.png | simple | <table><tr><td></td><td>Years</td><td>Survival rate (%)</td><td>95% confidence interval</td></tr><tr><td>Overall survival</td><td>2</td><td>90</td><td>80; 100</td></tr><tr><td></td><td>3</td><td>78</td><td>64; 96</td></tr><tr><td></td><td>5</td><td>69</td><td>53; 90</td></tr><tr><td>Disease-free survival</td><td>2</td>... |
58103f1e2d176e48d7384e766fd1d6f56317620c5f5fb646ff62957dd5d3e104.png | simple | <table><tr><td>Score</td><td>Symptoms</td></tr><tr><td>Grade 1</td><td>Local paraesthesia (anesthesia, tingling, stinging)</td></tr><tr><td>Grade 2</td><td>Hypersecretion (sweat, saliva)</td></tr><tr><td>Grade 3</td><td>Impaired vision, hearing, speech, dysphagia</td></tr><tr><td>Grade 4</td><td>Bilateral ptosis</td></... |
cf74c60a70c58c7dc74d04c1a58ed6692aff9b127e995a787c941c823accc70e.png | simple | <table><tr><td>Cell type</td><td>Species</td><td>Passage</td><td>Culture method</td><td>Reference</td></tr><tr><td>Chondrocyte</td><td>Human</td><td>P2</td><td>Monolayer + 3D</td><td>[7]</td></tr><tr><td>ADSC</td><td>Human</td><td>P4</td><td>Monolayer + 3D</td><td>[8]</td></tr><tr><td>SDSC</td><td>Human</td><td>P2</td>... |
644aa57d6a6df895a5337818b0b77054d5287563bd61de4206a9b900baba8919.png | complex | <table><tr><td rowspan="2">Num. of genes</td><td colspan="2">RSVM</td><td colspan="2">SVM-RFE</td><td colspan="2">SVM-<i>t</i></td></tr><tr><td>CV2</td><td>Mean SV</td><td>CV2</td><td>Mean SV</td><td>CV2</td><td>Mean SV</td></tr><tr><td>7129</td><td>22.09%</td><td>51.34</td><td>22.09%</td><td>51.34</td><td>22.09%</td><... |
506c73f8845b2ad3cf381808d65c673cd7413051edea62f7e3372b6208b5d68d.png | simple | <table><tr><td></td><td>Group 1</td><td>Group 2</td><td>p</td></tr><tr><td></td><td>N =58</td><td>N= 219</td><td></td></tr><tr><td>All-cause mortality, N (%)</td><td>5 (8.6%)</td><td>42 (19.9%)</td><td>0.05</td></tr><tr><td>Non-fatal ACS, N (%)</td><td>2 (3.4%)</td><td>32 (14.6%)</td><td>0.03</td></tr><tr><td>Stroke, N... |
10ae116fbb41d478a89ff056ef939eed03ddb86eb3e34a776f5ab015bc5059f0.png | complex | <table><tr><td></td><td></td><td>Baseline</td><td>60 mins</td><td>120 mins</td><td>180 mins</td><td>240 mins</td></tr><tr><td rowspan="2">EE</td><td>CON</td><td>4.29 ± 0.28</td><td>4.57 ± 0.41</td><td>4.28 ± 0.26</td><td>4.29 ± 0.35</td><td>4.42 ± 0.33</td></tr><tr><td>INS</td><td>4.01 ± 0... |
9e624384d9f81a57a732cc837a8452e2938ea4eced752a67aa148ed2f916e5bb.png | complex | <table><tr><td></td><td colspan="8">Library name</td></tr><tr><td></td><td>AA9</td><td>B421</td><td>CHORI-514</td><td>MCF7</td><td>PM-1</td><td>CHORI-510</td><td>CHORI-518</td><td>CHORI-520</td></tr><tr><td>Clinical sample designation</td><td>AA9</td><td>B421</td><td>S104</td><td>MCF-7</td><td>25-48</td><td>860-7</td><... |
ec6b9005cbb472707c5e418bb82e3f977a449c5175918ce33baf7eac3a4d37cd.png | simple | <table><tr><td>Gene</td><td>Cell locale</td><td>Tissue</td><td>Modality of expression</td></tr><tr><td>HSPA8</td><td>Cytosol. Translocate to nucleus and nucleoli upon heat shock. Surface of embryonic stem cells</td><td>Highly expressed in all tisuses</td><td>Constitutive. Moderately induced by heat shock</td></tr><tr><... |
1b6af52716846e52c0c7a722fd2c21d9c1532410d6654286283bdb503a92480e.png | complex | <table><tr><td rowspan="2"></td><td colspan="5">IAP</td><td></td></tr><tr><td>Normal (<i>n</i> =27)</td><td>Grade I (<i>n</i> = 55)</td><td>Grade II (<i>n</i> = 109)</td><td>Grade III (<i>n</i> = 78)</td><td>Grade IV (<i>n</i> = 32)</td><td><i>P</i>†</td></tr><tr><td>Shock</td><td>7 (26)</td><td>33 (60)</td><td>7... |
1df7a2e9a01916c376e95694aac119f2a091ac74927cf5e8a81963d315268e1e.png | simple | <table><tr><td>Study (reference)</td><td>Patients</td><td>Molecular marker</td><td>Ethnicity (Country)</td><td>Evaluation criteria</td><td>Sample size</td><td>Chemotherapeutic regimens</td><td>Outcomes</td></tr><tr><td>Goekkurt 2006, [11]</td><td>Patients with advanced GC</td><td>TS, GSTs, MTHFR, ERCC1-118</td><td>Euro... |
1e7a77c60f8dab670da4556138883d143ef782140319595fbbfad866b8644f1b.png | simple | <table><tr><td> </td><td>Median total number of lymph nodes for patients with nodal involvement</td><td>Median total number of lymph nodes for patients without nodal involvement</td><td>P-value</td></tr><tr><td>PCG</td><td>13.0 (10–17)*</td><td>14.0 (11–18)*</td><td>0.654</td></tr><tr><td> </td><td>PCG</td>... |
46ea7e32e97dc3704e4d6d869660b1f096d9f442903c72c38893cd8c2d7a0fdb.png | simple | <table><tr><td> </td><td>Number of patients</td><td>cEPCs(%)</td><td><i>P</i></td></tr><tr><td>Stenosis</td><td> </td><td> </td><td>0.012</td></tr><tr><td> <70%</td><td>48</td><td>0.052 ± 0.022</td><td> </td></tr><tr><td> ≥70%</td><td>60</td><td>0.091 ± 0.035</td><td> </td></tr><tr><td>Number of intr... |
4d638475ed7734376b5bcc77c7ccd0911f3f87ab734b0d534c852e457ee2c735.png | complex | <table><tr><td rowspan="2">Sample</td><td colspan="4">CO (μmol·g<sup>−1</sup>)</td></tr><tr><td>Anhydride</td><td>Phenol</td><td>Carbonyl and Quinone</td><td>Pyrone and Chromene</td></tr><tr><td>RN1</td><td>–</td><td>–</td><td>380</td><td>620</td></tr><tr><td>RN1P</td><td>–</td><td>... |
7bf3102186645d7679844ac82fd8d4ca8eb814df40e9df9b8933517cd1f1dedc.png | simple | <table><tr><td>Indication</td><td>Number</td></tr><tr><td>Renal impairment and acidosis</td><td>20</td></tr><tr><td>Renal impairment and hyperkalaemia</td><td>0</td></tr><tr><td>Renal impairment, acidosis and hyperkalaemia</td><td>6</td></tr><tr><td>Renal impairment, acidosis and convulsions</td><td>2</td></tr><tr><td>... |
74671c7f8ac848b19eb9441cd171279a6923dbe7ca73ffbb580a45a776244db9.png | complex | <table><tr><td>Class of agent</td><td>Chemical/brand name</td><td>Preventive targets</td></tr><tr><td rowspan="5">Selective estrogen receptor modulators and other hormonal agents</td><td>Tamoxifen</td><td>Breast</td></tr><tr><td>Arzoxifene</td><td>Breast</td></tr><tr><td>Acolbifene</td><td>Breast</td></tr><tr><td>Raxox... |
7841111e13aab9d10430e30682d157e6ac8d67552668d241169fd4de2c87118e.png | simple | <table><tr><td></td><td>Authors</td><td>Publication year</td><td>Patient number</td><td>Gender</td><td>Age</td><td>Open (O) or laparoscopic ablation (L)</td><td>Symptom related to lymphangioma</td><td>Left/right adrenal gland</td></tr><tr><td>1</td><td>Akand et al. [6]</td><td>2013</td><td>1</td><td>F</td><td>44</td><t... |
a1a140866d9558537935844888375c740ff96389e0b5ea6e8f88f593e433e004.png | complex | <table><tr><td colspan="2">Primary screening</td><td rowspan="2">Triage test</td><td rowspan="2">Test positivity (%)<sup>1</sup></td><td colspan="2">Sensitivity (95%-CI)</td><td colspan="2">Specificity (95%-CI)</td><td colspan="2">PPV (95%-CI)</td><td colspan="2">NPV (95%-CI)</td></tr><tr><td>Test</td><td>Threshold</td... |
57bf2709bf2fc765d2ad6bad04a14948cc3b78b3baf24c8177b471d02a7f7120.png | simple | <table><tr><td></td><td>Mean</td><td>Median</td><td>Inter-quartile range</td><td>Direct cost as % of total cost of illness</td></tr><tr><td>Total CNCD sample (<i>n</i> = 475)</td><td>1040.82</td><td>40</td><td>(1000, 0)</td><td>56.8 %</td></tr><tr><td>Chronic pain conditions (<i>n</i> = 126)</td><td>926.92</td><td>200<... |
851da1954da5962a31c9b13d12c8ef62eac94c64ce426ca0912160f0395a788e.png | complex | <table><tr><td>GenBank accession no.</td><td>Gene name</td><td>Gene symbol</td><td>Fold change (HN2/control)a</td><td>Summary function</td></tr><tr><td colspan="5">Highest response to HN2</td></tr><tr><td> BG080773</td><td>AMP deaminase 3</td><td><i>Ampd3</i></td><td>4.10</td><td>Purine metabolism</td></tr><tr><td> BG0... |
2c948e8063cb063ae777640b964f694a489e833c04d95fc971a6875a731341ff.png | complex | <table><tr><td></td><td colspan="3">icddr,b service area</td><td colspan="3">Government service area</td></tr><tr><td>Cause of death</td><td>Male</td><td>Female</td><td>Total</td><td>Male</td><td>Female</td><td>Total</td></tr><tr><td>Communicable diseases (CDs)</td><td>20.5</td><td>16.8*</td><td>18.8</td><td>24.3</td><... |
fbc17b082264adc8e4340d63c3389dc170df5351ac4746bea3495cf07d771cbf.png | complex | <table><tr><td rowspan="2">Element</td><td>Certified value</td><td>Amino acids</td><td>Glucose</td><td>Lipids</td></tr><tr><td colspan="4">[<i>μ</i>g/kg]</td></tr><tr><td>As</td><td>26.67 ± 0.41</td><td>26.2 ± 1.3</td><td>27.2 ± 1.2</td><td>26.9 ± 1.2</td></tr><tr><td>Cd</td><td>22.79 ± 0.... |
115467db76b3ba5828b9cdda8ce0475ff8b598a89b71bef6ebd3808e244caea8.png | simple | <table><tr><td>Type</td><td>Number of reads</td><td>Percentage (%)</td></tr><tr><td>Total unique reads</td><td>9,664,154</td><td>100</td></tr><tr><td>Reads mapping to the transcripts</td><td>9,193,054</td><td>95.13</td></tr><tr><td>Reads mapping to target site</td><td>6,916</td><td>0.072</td></tr><tr><td>Total Number o... |
de42513fc337cf05e8416296323e1efdff89f898357d4e9690fc6e3acbc7a481.png | complex | <table><tr><td> </td><td>Trial</td><td><i>N</i>, inclusion criteria</td><td>Dose (dose per fraction)</td><td>Outcome</td></tr><tr><td rowspan="2">Early hypofractionation trials</td><td>Lukka et al. [44]</td><td>936GS 6–10</td><td>52.5 Gy (2.625 Gy)66 Gy (2 Gy)</td><td>40% versus 43% 5-year freedom from biochemica... |
8ad82cffa8204bea32b9eec31bb9d54708a6b4433107e5eabd8519e3d1349981.png | complex | <table><tr><td>Implicit review process measure</td><td colspan="2">Acceptable care*</td><td colspan="2">Extremely appropriate care**</td></tr><tr><td></td><td><i>Reviewer 1</i></td><td><i>Reviewer 2</i></td><td><i>Reviewer 1</i></td><td><i>Reviewer 2</i></td></tr><tr><td>Initial data gathering by physician about acute ... |
ab6b475265f04e1687b49be4f50dac3deacc3fc8d7ad8dc7ae9a8c2275b6087b.png | complex | <table><tr><td>Score for sorting</td><td colspan="4">KSEARCH</td><td colspan="2">SANS</td><td>BLAST</td></tr><tr><td></td><td><i>k</i> = 5</td><td><i>k</i> = 6</td><td><i>k</i> = 7</td><td><i>k</i> = 8</td><td><i>w</i> = 1000</td><td><i>w</i> = 2000</td><td></td></tr><tr><td>Native</td><td>0.51</td><td>0.55</td><td>0.4... |
d71aecdf807598c81ef1199517251a87ef72d751b4ec2f34cce1641e7457ee6a.png | complex | <table><tr><td></td><td></td><td colspan="3">Mean accuracy</td><td colspan="4">Mean reaction time (ms)</td></tr><tr><td>Task</td><td>Group</td><td>RT</td><td>ST</td><td>NT</td><td>RT</td><td>ST</td><td>NT</td><td>RG</td></tr><tr><td>CS</td><td>High</td><td>1.00</td><td>0.97</td><td>0.88</td><td>346.72</td><td>390.01</t... |
8275d9ec26fb86648d6b4ce076c5652d895791fd69f141b3d2f23515433f8cb8.png | simple | <table><tr><td>Category #</td><td>Job title</td><td># of participantsinterviewed</td></tr><tr><td>1</td><td>Laboratory Manager</td><td>3</td></tr><tr><td>2</td><td>Transfusion Safety Officer</td><td>2</td></tr><tr><td>3</td><td>Lab Technologist (Blood Bank)</td><td>9</td></tr><tr><td>4</td><td>Physicians - Blood Bank</... |
a1ff08ecd3b1e3aef6504348b44719be914693afbdad6d6e6f55fed70533105d.png | complex | <table><tr><td> </td><td>N</td><td><i>Whole sample</i></td><td><i>Boys</i></td><td><i>Girls</i></td><td>F</td><td>R<sup>2</sup></td></tr><tr><td colspan="7"><i>Age 11</i></td></tr><tr><td colspan="7"> Self-report</td></tr><tr><td>Behavior problems</td><td>5057</td><td>8.79 (5.30)</td><td>9.37 (5.36)</td><td>8.28 (5.20)... |
327649e73db0fc33ee42dd4cd197227b696fe18e920cf8c3faa36fb5ff4eb2d1.png | simple | <table><tr><td></td><td>Preoperatively</td><td>1-Week</td><td>1-Month</td></tr><tr><td>cSystolic</td><td>145</td><td>113</td><td>120</td></tr><tr><td>cDiastolic</td><td>99</td><td>68</td><td>78</td></tr><tr><td>cPP</td><td>46</td><td>45</td><td>42</td></tr><tr><td>PWV</td><td>11.6</td><td>10.6</td><td>10.9</td></tr><tr... |
d1c62979547577da449abce6bc47d0a691a54f35fa801030450a2aae0c2f9008.png | simple | <table><tr><td>Description</td><td>Selected study</td></tr><tr><td>Critical endpoint</td><td>Acute irritation of the eyes and upper airways</td></tr><tr><td></td><td>A few (4 out of 27) individuals reacted with additional cough and slight airway obstruction</td></tr><tr><td>Source</td><td>The Health Council of the Neth... |
728c175a562a6f5b946b08f28540fb6b6a34e457ee2721d7609e11202f090aa4.png | complex | <table><tr><td colspan="2">Variables</td><td><i>n</i> (%)</td></tr><tr><td rowspan="4">Marital status</td><td>single</td><td>47 (13.6)</td></tr><tr><td>married</td><td>259 (75.1)</td></tr><tr><td>divorced</td><td>37 (10.7)</td></tr><tr><td>widow</td><td>2 (0.6)</td></tr><tr><td rowspan="4">Education</td><td>primary</td... |
6dc6bf92a2e86fe4eb05cc05e077485440b0e5f26ce284e6b3124d76eb36ec71.png | simple | <table><tr><td>Outcomes</td><td>Standard Therapy (n = 32)</td><td>Acupuncture (n = 34)</td><td>p*</td></tr><tr><td><i>Primary outcomes </i></td><td></td><td></td><td></td></tr><tr><td><i>VAS</i></td><td></td><td></td><td></td></tr><tr><td>Mean VAS score at baseline (SD)</td><td>8.02 (1.69)</td><td>7.81 (1.48)</td><td>0... |
7f75bd917ce831bfdd93cad6479381eefc7d7f0fa5b96543800ad6c100299f87.png | complex | <table><tr><td>Predictor</td><td>Odds Ratio</td><td colspan="2">95% Confidence Interval</td></tr><tr><td>Age</td><td>0.97</td><td>0.95</td><td>1.00*</td></tr><tr><td>Education</td><td>0.93</td><td>0.87</td><td>1.01</td></tr><tr><td>Services</td><td>0.98</td><td>0.84</td><td>1.14</td></tr><tr><td>Partner support</td><td... |
121f8c0d991b1bef1f41cf1f06fc46ef871efdfe6e9b8a47b31386cae707683a.png | simple | <table><tr><td>Surgical procedure</td><td>Vault prolapse</td><td>POP-Q III</td><td>POP-Q IV</td></tr><tr><td> Sacrospinous fixation </td><td> 4 </td><td> 5 </td><td> 23 </td></tr><tr><td> Anterior colporrhaphy </td><td> 2 </td><td> 5 </td><td> 23 </td></tr><tr><td> Enterocele repair </td><td> 3 </td><td> 1 </td><td> 20... |
b9696579b6e66dde557cdbadbfb67f4781decced124419e6015095ceb47a6e89.png | simple | <table><tr><td>Class</td><td>TP rate</td><td>FP rate</td><td>Precision</td><td>Recall</td><td><i>f</i>-measure</td><td>ROC area</td><td>Accuracy</td></tr><tr><td>Migraine</td><td>1</td><td>1</td><td>0.716</td><td>1</td><td>0.835</td><td>0.5</td><td>100.00%</td></tr><tr><td>Cluster</td><td>0</td><td>0</td><td>0</td><td>... |
81ac90db584ee86f4672404fa64cab5496da24335afbe75fbc5de4964290256c.png | simple | <table><tr><td> </td><td>Number of respondents</td><td>Percentage (95% CI)</td></tr><tr><td>Equipment cost</td><td>177</td><td>89.4% (85.7-93.1)</td></tr><tr><td>Training costs</td><td>146</td><td>73.7% (68.4-79)</td></tr><tr><td>Challenges in training</td><td>106</td><td>53.5% (47.5-59.5)</td></tr><tr><td>Transport ti... |
8f192f843addfe83bffae0a5ecc3ea3652029443983c029a16975aa3ced4beb8.png | simple | <table><tr><td>Variable</td><td>PPR</td><td>SE</td><td><i>p</i>-Value</td><td>(95% CI)</td></tr><tr><td>L<sub>Night</sub></td><td>0.969</td><td>0.031</td><td>0.32</td><td>(0.91, 1.031)</td></tr><tr><td>Sensitivity</td><td></td><td></td><td></td><td></td></tr><tr><td>Not sensitive</td><td>1</td><td></td><td></td><td></t... |
084a154a5984c363a5d5a1742fdf83d365a33fd97a319224a1a4934c7cb0e64b.png | simple | <table><tr><td>Hematological parameter</td><td><i>N</i></td><td>Median</td><td>Mean</td><td>SE</td><td>Min–Max</td></tr><tr><td>PCV (%)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Adult</td><td>19</td><td>19.0</td><td>19.42</td><td>1.38</td><td>5–27</td></tr><tr><td> Juvenile</td><td>6</t... |
cb94733f8ef88d6354cfe2b1267d454a7611de234fd041f63f8836887661d20c.png | simple | <table><tr><td>Average hours per month</td><td>Programs Reported Resident UseNo. (%)</td></tr><tr><td>< 1 h</td><td>17 (38)</td></tr><tr><td>1–2 h</td><td>14 (31)</td></tr><tr><td>3–5 h</td><td>2 (4)</td></tr><tr><td>6–10 h</td><td>1 (2)</td></tr><tr><td>> 10 h</td><td>1 (2)</td></tr><tr><td>No ... |
0db0e1ced3b61c946b9fdd2fa07b947215f9910c7f488b623cbe829af1541ee0.png | complex | <table><tr><td rowspan="3">Antibiotics</td><td colspan="3">Cattle (3 isolates)</td><td colspan="3">Buffalo (1 isolates)</td><td colspan="3">Pig (6 isolates)</td><td colspan="3">Total isolates (10)</td></tr><tr><td>R</td><td>MS</td><td>S</td><td>R</td><td>MS</td><td>S</td><td>R</td><td>MS</td><td>S</td><td>R (%)</td><td... |
24d0d076693ae018e04e577cd2f700d98b2cf41e0301d6646c42037f0ea87c24.png | complex | <table><tr><td rowspan="2">Economic Quantiles</td><td colspan="3">Tobacco Use Prevalence (TP)</td><td colspan="3">Tobacco Use Quantities (TQ)</td></tr><tr><td>Men</td><td>Women</td><td>All</td><td>Men</td><td>Women</td><td>All</td></tr><tr><td>Poorest</td><td>26.0</td><td>4.1</td><td>14.0</td><td>12.6</td><td>8.4</td><... |
a47e73c7dfd87e4abd52660388bda8e2e0492500f6784c03cbf4afea90684431.png | simple | <table><tr><td>rs4880 T > C</td><td>Cases, <i>n</i> (%)</td><td>Controls, <i>n</i> (%)</td><td>OR (95% CI) <sup>a</sup></td><td><i>p</i><sup>a</sup></td></tr><tr><td>TT</td><td>319 (69.35%)</td><td>426 (80.37%)</td><td>Reference</td><td>-</td></tr><tr><td>TC</td><td>111 (24.13%)</td><td>99 (18.68%)</td><td>1.35 (0.7... |
72fca98642a343d94c6192a466e0bab9aa682c4ff76ff5c0facf899fc13d4bf2.png | complex | <table><tr><td></td><td colspan="4">Reference SSC-I (cos 0.98)</td></tr><tr><td>SSC-II</td><td>DISO</td><td>SPE</td><td>PRGE</td><td>CHED</td></tr><tr><td>Rec</td><td>89.0%</td><td>94.5%</td><td>59.7%</td><td>49.6%</td></tr><tr><td>Prec</td><td>71.6%</td><td>90.0%</td><td>96.8%</td><td>49.4%</td></tr><tr><td>F-meas</td... |
e245282a8658cf0d4fbc66080dc289d3dd7daea99557c047ede41264417bc72e.png | complex | <table><tr><td>Outcomes</td><td>Instrument</td><td>t0</td><td>t1</td><td>t2</td><td>t3</td><td>t4</td><td>t5</td><td>t6</td></tr><tr><td colspan="9">Primary endpoint</td></tr><tr><td>Overall 2-year survival</td><td>Medical log (ongoing assessment)</td><td colspan="7"></td></tr><tr><td colspan="9">Secondary endpoints</t... |
519e23787e680fa0ddb77ee6074e45ae2f0c5489c03b1b1a22cda753b5151b2b.png | complex | <table><tr><td><i>Individual components of global assessment of inflammation</i></td><td colspan="2"><i>Patients with grade 0,</i> n <i>(%)</i></td></tr><tr><td> </td><td><i>Difluprednate 0.05% (</i>n=<i>39)</i></td><td><i>Prednisolone acetate 1% (</i>n=<i>40)</i></td></tr><tr><td>Anterior chamber cell</td><td>30 (78.9... |
83357e5932eef05d0eb3b87b1cb42c844d8ee3114f83821f08eab6835dbd8cb1.png | simple | <table><tr><td></td><td></td><td>Decreased dose</td><td>Stable dose</td><td>Increased dose</td><td>Total</td></tr><tr><td>DAS</td><td>Remission: < 1.6, N (%)</td><td>257 (13)</td><td>1149 (56)</td><td>629 (31)</td><td>2035 (100)</td></tr><tr><td></td><td><sup>a</sup>LDA: 1.6–2.4, N (%)</td><td>179 (12)</td><td... |
63274e0b02012dc136962e7e37542f520a6171ef3f88a8027c255cc98f6fd8b2.png | simple | <table><tr><td>Material Scan Rate Cathodic Threshold Potential</td><td><i>i</i><sub>corr</sub><i><sup>f</sup></i><sup>w</sup> (A/cm2)</td><td>CR<i><sup>f</sup></i><sup>w</sup> (mm/year)</td><td><i>E</i><sub>corr</sub><i><sup>f</sup></i><sup>w</sup> (V<i>vs.</i> SCE)</td><td><i>i</i><sub>corr</sub><i><sup>b</sup></i><su... |
4a73f716af05e5138f95044d9c92051ff04916767341baef25cf8db6d37a7c64.png | simple | <table><tr><td><i>Ingredients</i></td><td><i>% of DM</i></td></tr><tr><td><i>Mix Silage</i></td><td>39.00</td></tr><tr><td><i>Mix Hay</i></td><td>5.00</td></tr><tr><td><i>Barley</i></td><td>18.09</td></tr><tr><td><i>Oats</i></td><td>15.12</td></tr><tr><td><i>Rape Seed Cake</i></td><td>6.48</td></tr><tr><td><i>Rape Seed... |
ee35c86af1c0d672a0464dd652ba166c9cf938cb72106bbf3f991933c89cf795.png | simple | <table><tr><td>Isolate</td><td>Source</td><td>BioSample ID</td><td>SRA Run</td><td>GenBank accession number</td><td>PubMLST ID</td><td><i>rpoB</i> allelic type (AT)</td><td>MLST ST<sup>a</sup></td><td>Novel MLST AT or ST<sup>b</sup></td></tr><tr><td>FSL H7-0926</td><td>Pasteurized 2 % milk</td><td>SAMN03800014</td><td>... |
15b67cee1f21cc1dda659be106a5cc9c538fbec3b1165f54935a3589ee72b38f.png | simple | <table><tr><td>Main nutrients </td><td>Rice porridge</td><td>Rice cereal *</td><td>Hard-boiled egg yolk</td></tr><tr><td>Energy, including dietary fibre (kJ)</td><td>158</td><td>1537</td><td>1450</td></tr><tr><td>Protein (g)</td><td>0.7</td><td>6.8</td><td>16.1</td></tr><tr><td>Fat (g)</td><td>0.1</td><td>1.1</td><td>3... |
eb64c5b2908d0deec3d641acba5b89bd8897127a521da1b8a9b5038714bf6980.png | simple | <table><tr><td>Variable</td><td>Laser</td><td>Steel</td><td>Total</td><td>p-value</td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td>0.548</td></tr><tr><td><i>Mean</i></td><td>65.2</td><td>67.4</td><td>66.3</td><td> </td></tr><tr><td><i>Range</i></td><td>-</td><td>-</td><td>34-87</td><td> </td></tr><tr><td><i>S... |
4c2854d228e35fda8e4d4cbc7ad28be0363640e31aec8c7fc8d178c3d8fa241e.png | complex | <table><tr><td> </td><td colspan="7">1991-1996</td><td colspan="7">1997-2001</td><td colspan="7">1991-2001</td></tr><tr><td> </td><td>Deaths</td><td colspan="3">Controlling for age</td><td colspan="3">Controlling for all variables (1)</td><td>Deaths</td><td colspan="3">Controlling for age</td><td colspan="3">Controllin... |
75ae05db73ad7a4163cdda927712abd939838b4ddfc9ae779926a61c6620fc26.png | simple | <table><tr><td>Cluster description</td><td>Codon</td><td>Size</td><td>Example organism (locus)</td></tr><tr><td>Selenocysteine</td><td></td><td></td><td></td></tr><tr><td>Formate dehydrogenase α subunit</td><td>TGA</td><td>45</td><td>Escherichia coli (b1474)</td></tr><tr><td>Selenide water dikinase</td><td>TGA</td... |
6a8e16da199b55d219454c5507ad53121a023e8b67ca718b8750b613e2af5fc8.png | complex | <table><tr><td></td><td colspan="3">Intention-to-treat analysis</td><td colspan="3">Per protocol analysis</td></tr><tr><td></td><td>1 Hz (<i>n</i> = 22)</td><td>25 Hz (<i>n</i> = 24)</td><td>Group comparison</td><td>1 Hz (<i>n</i> = 17)</td><td>25 Hz (<i>n</i> = 23)</td><td>Group comparison</td></tr><tr><td>Treatment p... |
4646c5af634a932915f27b85dd61d97b1600e3a3bfcd1155f520508ed67a4ff0.png | complex | <table><tr><td>Variables</td><td></td><td colspan="2">Patients</td><td>KRAS</td><td>NRAS</td><td>BRAF</td></tr><tr><td></td><td></td><td><i>n</i></td><td>%</td><td><i>n</i></td><td><i>n</i></td><td><i>n</i></td></tr><tr><td>Age</td><td>≤ 55</td><td>14</td><td>64</td><td>4</td><td>1</td><td>3</td></tr><tr><td></td... |
54276a86973717f5b1e0961041056a5682b8d462f252c6a2fcfc5181a601e7bc.png | complex | <table><tr><td></td><td colspan="4">Alcohol intake (g/day)</td></tr><tr><td></td><td>0</td><td>0.1–5</td><td>5.1–15</td><td>>15</td></tr><tr><td>No. of participans</td><td>10,153</td><td>22,249</td><td>11,734</td><td>1,097</td></tr><tr><td>Age at enrollment (mean)</td><td>39.8</td><td>39.7</td><td>40.5</... |
36bdabae3fa9efc1c66488814861c65dfe357581268e666270072e94d3b69a0e.png | complex | <table><tr><td> </td><td colspan="2">Location</td><td rowspan="2">Group</td><td colspan="5">IHC grade<sup>#</sup></td><td rowspan="2"><i>P</i> value*</td></tr><tr><td> </td><td>Stroma</td><td>Cancer nest</td><td>−</td><td>+</td><td>++</td><td>+++</td><td>++++</td></tr><tr><td rowspan="2"><i>α</i>-SMA</td><td... |
ca322fb97810764fbba3a7b83b46eb975ccc07962cd586a9f402c3385ffd68a8.png | simple | <table><tr><td> </td><td>Japanese (<i>n</i>22)</td><td>Thai (<i>n</i>27)</td></tr><tr><td> </td><td>Mean ± SD (range)</td><td>Mean ± SD (range)</td></tr><tr><td>Age (years)</td><td>21.5 ± 0.7 (21–24)</td><td>21.2 ± 2.2 (18–25)</td></tr><tr><td>Height (cm)</td><td>159.9 ± 5.9 (151.7-... |
368653111d46c06feaddcc99be5500cf0a27ad1b3f21b902e2375d9b05729f3c.png | complex | <table><tr><td rowspan="2"> </td><td colspan="3">Culture-Gram-PCR result<sup>b</sup></td></tr><tr><td>All tests negative</td><td>Isolated RT-PCR positive</td><td>All tests positive</td></tr><tr><td> </td><td>(n=329)</td><td>(n=20)</td><td>(n=75)</td></tr><tr><td>Age in years (median, range)</td><td>9 (0–64)</td><... |
af5777833e2fc8d220e8d35d5a417bacaf8c185971a089b0042620bba9067560.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Male</td><td colspan="4">Female</td><td colspan="4">Total</td></tr><tr><td>Cases</td><td>n</td><td>p-y</td><td>Rate</td><td>Cases</td><td>n</td><td>p-y</td><td>Rate</td><td>Cases</td><td>n</td><td>p-y</td><td>Rate</td></tr><tr><td>18–20 years</td><td>175</td><td>61,... |
bc758f6c8de05dd430a2bf4e8f071a10566ff58d8d372ed30d6e999233d7ebf5.png | complex | <table><tr><td>Specific primer</td><td>Primer sequences (5′–3′)</td></tr><tr><td rowspan="2">N type <i>DlRans</i></td><td>Forward: AAGGACAGCTCTCATGGCTTTGC</td></tr><tr><td>Reverse: TGCCTCCATCACCGACGATGAC</td></tr><tr><td rowspan="2">D type <i>DlRans</i></td><td>Forward: TAGTGATCGTCGGCGATGGTGG</td></tr... |
1e33d01e678a9cfd3b05a30d5d9de5f3584d580ac11c08aad8e986d28eac1b4f.png | complex | <table><tr><td></td><td colspan="3">Increasing ANNV (> 4)</td><td colspan="3">Stable ANNV (-4 to 4)</td><td colspan="3">Decreasing ANNV (< -4)</td></tr><tr><td>Parameter</td><td>PCa (n = 22)</td><td>BPH (n = 16)</td><td>p-value</td><td>PCa (n = 17)</td><td>BPH (n = 124)</td><td>p-value</td><td>PCa (n = 10)</td><t... |
fcf10846c7ff7be69365b55c971c8e4e604ea5e48b8eca1d58d62f0f26d2eff7.png | simple | <table><tr><td>Group</td><td>Swell degree (mg)</td><td>Inhibition rate (%)</td></tr><tr><td>Fenli</td><td>5.13 ± 0.68</td><td>69.15</td></tr><tr><td>DE MDTS</td><td>5.86 ± 1.76</td><td>64.76</td></tr><tr><td>Control</td><td>16.63 ± 1.57</td><td> </td></tr></table> |
169fd98530a563c3089ae1d756afbdd0aceca336399f54c6147290f7c16e87dd.png | simple | <table><tr><td>Workflow</td><td>Sequential</td><td>Parallel</td></tr><tr><td>Preprocess (clipOverlap)</td><td>2.82</td><td>2.91</td></tr><tr><td>SNV: mutationSeq</td><td>5.68</td><td>5.99</td></tr><tr><td>SNV: Strelka</td><td>2.60</td><td>4.49</td></tr><tr><td>CNV: Titan</td><td>29.34</td><td>36.31</td></tr><tr><td>CNV... |
431141e08b808b23474824f4c64b3711ef677890c066e7a1d5b2a9e12f1924a1.png | complex | <table><tr><td>Gene Name</td><td>Primers</td></tr><tr><td rowspan="2"><i>Rbcl</i> (ribulose-1,5-bisphosphate carboxylase/oxygenase: Genbank-KR914695.1)</td><td><i>Rbcl1</i>: ACGAATGTTTACGCGGTGGTCT</td></tr><tr><td><i>Rbcl2</i>: GGTACACCCAACTCCTTAGCA</td></tr><tr><td rowspan="2"><i>CrtZ</i> (carotenoid hydroxylase: Genb... |
7a8a221070adffee699fedac0fda4adef5d1d057feecc5c274c287997f209bd4.png | complex | <table><tr><td> </td><td> </td><td> </td><td colspan="3"><i>WALK</i></td><td> </td><td colspan="3"><i>JOG</i></td><td> </td></tr><tr><td>Phase</td><td>Joint</td><td>Plane</td><td>Barefoot</td><td>Thong</td><td><i>p;<0.05</i></td><td>95% CI</td><td>Barefoot</td><td>Thong</td><td><i>p;<0.05</i></td><td>95% CI</td><... |
8c1317f4a3d67c736565237a9577e55a7533a0f2e9359587e6ce46d43b5115df.png | complex | <table><tr><td rowspan="3">Factors</td><td colspan="6">The effects of selection criteria fulfillment and AFP on recurrence-free survival adjusted for</td></tr><tr><td colspan="2">Microvascular invasion</td><td colspan="2">Poor tumor differentiation</td><td colspan="2">Recipient age</td></tr><tr><td>HR (95 % CI)</td><td... |
ce546fde18c0b03f4131a59cd8bf8583f0f44ec57e746d6c686bebc71e4cb1a1.png | simple | <table><tr><td>Test</td><td>Method</td></tr><tr><td>Blood testsAs listed in table 1, plus:</td><td></td></tr><tr><td> Collagen C-telopeptide (CTX)Osteocalcin (OC)</td><td>Roche Elecsys beta cross-lapsRoche Elecsys 2010Canterbury District Health Board Laboratory</td></tr><tr><td>Weight at baseline and 6 months</td><td>T... |
4e40215eb5f5bc2052eb3d441b34aa7ad15f5777ea9ad40947d74d2b88a27e65.png | simple | <table><tr><td></td><td>Rule role</td><td>Rule example</td><td>Location term</td></tr><tr><td><i>Ex. 1</i></td><td>Type disambiguation</td><td>IF <i>dead, decaying </i>in term THEN type =Env</td><td><i>dead animal </i>(Host) becomes <i>dead animal </i>(Env)</td></tr><tr><td><i>Ex. 2</i></td><td>Boundary extension</td><... |
209a0e4cbf539d2eaebe72c1e1c2a4c4668720bd4d58e2328b653c7d691ac646.png | complex | <table><tr><td rowspan="2">Rabbit antibody</td><td colspan="4">Neutralization titers</td><td rowspan="2">Dog Sera A/P<sup>a</sup></td><td colspan="2">Serological prevalence</td></tr><tr><td>3–68</td><td>W191R</td><td>L198 T</td><td>A128T</td><td>Arrival<sup>a</sup></td><td>Post<sup>a</sup></td></tr><tr><td>3̵... |
31e68bc36485073925aa4960a8d4edfa617154da02904be02948ab415bd2c259.png | complex | <table><tr><td colspan="2"></td><td>Clients & informal caregivers (n = 28)</td><td>Health care providers (n = 20)</td></tr><tr><td rowspan="2">Urban (n = 16)</td><td>Male</td><td>4</td><td>0</td></tr><tr><td>Female</td><td>8</td><td>4</td></tr><tr><td rowspan="2">Rural (n = 32)</td><td>Male</td><td>1</td><td>1</td>... |
e30bda0d69523a0cb8ac1458c056b76f522b8e4d8400ce2cf26d25d105e1d295.png | complex | <table><tr><td></td><td colspan="6">Median duration of stay (days) for SARI cases</td><td colspan="6">Median duration in ICU (days) for SARI cases with ICU treatment</td><td colspan="6">Median duration of ventilation (hours) for ventilated SARI cases</td></tr><tr><td>Case definition</td><td>< 5</td><td>5–14</t... |
29fc23580f14c1fba10d72e9f016b0d89c39f0f339358f71a452d4eaaab073a4.png | simple | <table><tr><td>Gene id</td><td>Contiguous<i>E. histolytica </i>DNA region ID</td><td>Length (bp)</td><td>Location of SNP(s) (bp)</td></tr><tr><td>EHI_080100</td><td>DS571720</td><td>5179</td><td>2725-2730</td></tr><tr><td>EHI_065250</td><td>DS571302</td><td>38246</td><td>10296-10318</td></tr></table> |
bc15280aa1a9647bad90edfee908f3a2a4a85f7653d23dac49b4ef35c8411373.png | simple | <table><tr><td>Antimicrobial agents</td><td>MIC range</td><td>MIC<sub>50</sub></td><td>MIC<sub>90</sub></td><td>Resistance (%)</td><td>Susceptible (%)</td></tr><tr><td>Cefoperazone–sulbactam</td><td>16–256</td><td>64</td><td>128</td><td>85.4</td><td>4.2</td></tr><tr><td>Ampicillin–sulbactam</td><td>16... |
225ddd16bc59a0d213b56f683e211788bb750b909a0d00f651cdcd1156fa6c4c.png | simple | <table><tr><td>Group</td><td>Sequence</td><td>Repeat times</td></tr><tr><td>A1</td><td>DYDRYSSALIAA</td><td>5</td></tr><tr><td>A3</td><td>YWTPGYTPSQTE</td><td>1</td></tr><tr><td>A7</td><td>NNSRDTALRWFV</td><td>1</td></tr><tr><td>A13</td><td>GQPKTFLSVSEL</td><td>5</td></tr></table> |
0409626d7667049f261c8163bfd55e0e56386abe5c1f88ef1f2c3a67c1b57d1e.png | complex | <table><tr><td rowspan="2"></td><td>PCOS</td><td>Controls</td><td rowspan="2"><i>p</i>-value</td></tr><tr><td>(<i>N</i> = 8048)</td><td>(<i>N</i> = 32192)</td></tr><tr><td></td><td><i>n</i> (%)</td><td><i>n</i> (%)</td><td></td></tr><tr><td>Age, years</td><td></td><td></td><td></td></tr><tr><td> Mean (SD)</td><td>28.11... |
f45c48402cdd9fc81d3bafe70519a239f398da06db58fd9f3c2f09d4f8626a98.png | simple | <table><tr><td>No.</td><td>Primer’s name</td><td>Forward sequence</td><td>Reverse sequence</td><td>Annealing time and temperature</td></tr><tr><td>1</td><td><i>otud4</i></td><td>CCACCTCCTGCAGAACAAAAG</td><td>GGGTCTTGGTAAAGGCTCATT</td><td>15 s/60 °C</td></tr><tr><td>2</td><td><i>cx43</i> (<i>gja1</i>)</td><td... |
0e3b755903a7cc6905df5c9b192c7b70595361a7a4b0c4138d4b746ae8f42ab7.png | simple | <table><tr><td>Subjects</td><td>/a/</td><td>/e/</td><td>/i/</td><td>/o/</td><td>/u/</td><td>Total</td></tr><tr><td>Viet. hyponasality</td><td>19.0</td><td>7.0</td><td>9.0</td><td>6.0</td><td>7.0</td><td>9.6</td></tr><tr><td>Viet. hypernasality</td><td>22.5</td><td>54.5</td><td>45.5</td><td>28</td><td>23</td><td>34.7</t... |
f1a59d077b5995418b5b676797df4318c2bd3390189af8472ccceafce1874d68.png | complex | <table><tr><td>Type</td><td>Div</td><td>Cov</td><td colspan="5">Caller</td></tr><tr><td></td><td>(%)</td><td></td><td>GATK UG</td><td>Platypus</td><td>SAMtools</td><td>GATK HC</td><td>FreeBayes</td></tr><tr><td>SNP</td><td>0.05–1.00</td><td>10</td><td>87.3–89.8 (A)</td><td>77.6–83.0 (C)</td><td>85.9&#... |
4d40bebcd3bc07d8175d952f703dcdf040d35dcfb00302068ecad47d8b1902fe.png | simple | <table><tr><td>Organism</td><td>Inpatient</td><td>Outpatient</td><td>Pediatrics</td><td>Missing</td><td>Total</td></tr><tr><td>Streptococcus species</td><td>162</td><td>16</td><td>19</td><td>9</td><td>206</td></tr><tr><td>Neisseria species</td><td>94</td><td>11</td><td>2</td><td>0</td><td>107</td></tr><tr><td>Haemophil... |
82be55fed07e318433a4907e4cfd27116b92dc2972d41f6af26c54dff9f74407.png | complex | <table><tr><td colspan="6">Mesencephalon</td></tr><tr><td>Most Discriminative Texture Parameters on Patients</td><td>p-values (patients)</td><td>p-values (controls)</td><td>Most Discriminative Texture Parameters on Controls</td><td>p-values (controls)</td><td>p-values (patients)</td></tr><tr><td>Teta4</td><td><0.001... |
c819609bb392443cd5699aaa135e53be4677c799bad6d7b8bb3b141c8ca58306.png | complex | <table><tr><td> </td><td>Administration</td><td>Clearance</td><td colspan="2">Side effects</td></tr><tr><td>GLP-1R agonist</td><td>Subctaneous</td><td> </td><td>Weight loss</td><td>Gastrointestinal tract (GIT)</td></tr><tr><td>Exenatide</td><td>Twice a day, once a week</td><td>Renal</td><td>+</td><td>++/±*</td></t... |
075c51de07a2366c7287590ec51a8a09319b9bffdf63f2551c81a493243a44bf.png | simple | <table><tr><td>MIGS ID</td><td>Property</td><td>Term</td><td>Evidence code<sup>a</sup></td></tr><tr><td></td><td>Classification</td><td>Domain <i>Bacteria</i></td><td>TAS [37]</td></tr><tr><td></td><td></td><td>Phylum <i>Bacteroidaeota</i></td><td>TAS [3]</td></tr><tr><td></td><td></td><td>Class <i>Flavobacteriia</i></... |
c1164584091236746439307ffbff4d2093c3a58ad2f7b60946936b525175d9b0.png | complex | <table><tr><td>Included trials</td><td colspan="2">Selective head cooling</td><td colspan="3">Whole body cooling</td></tr><tr><td></td><td>Gunn 1998</td><td>Gluckman 2005</td><td>Shankaran 2002</td><td>Shankaran 2005</td><td>Eicher 2005</td></tr><tr><td>Design</td><td>RCT</td><td>RCTMulticenter</td><td>RCTMulticenter</... |
372f586139094f33a33153ed6a51bdae6b87740604390e2b3d71fa25a1be5cc7.png | simple | <table><tr><td>Chromosome</td><td>Number of SNPs in EU regions</td><td>Sequence length of EU regions (Mb)</td><td>SNP density in EU regions (Kb/SNP)</td><td>Number of SNPs in HET regions</td><td>Sequence length of HET regions (Mb)</td><td>SNP density in HET regions (Kb/SNP)</td><td>Number of SNPs</td><td>Sequence lengt... |
6368514eb6f4bd597afafb233896c9ac788e035b8d03fdfac30e2f40acb1ad63.png | simple | <table><tr><td>Candidate Biomarker</td><td>Comparison</td><td>Difference</td><td>Lower CI</td><td>Upper CI</td><td>Q-value</td></tr><tr><td>CEA</td><td>Malignant/Non-malignant</td><td>1.97</td><td>1.08</td><td>2.85</td><td>0</td></tr><tr><td>CEA</td><td>Malignant/Healthy</td><td>2.11</td><td>1.02</td><td>3.19</td><td>0... |
db3c741a41749febcdee935b3814b7f976304f7a920fc657e155574ee64b1175.png | complex | <table><tr><td colspan="2">Health professional/service</td><td>Communications sent out</td><td>Communications received</td></tr><tr><td>6</td><td>Oncologist</td><td>0</td><td>1</td></tr><tr><td>7</td><td>Psychologist</td><td>0</td><td>1</td></tr><tr><td>9</td><td>Neurosurgeon</td><td>5</td><td>1</td></tr><tr><td>16</td... |
3d2e8b9eec991a72861bfc7ea4bc237f5e5ec91b6a782febfe0571e0900de929.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Free attention (FA)</td><td rowspan="2"> </td><td colspan="2">Attention to the right (AR)</td><td rowspan="2"> </td><td colspan="2">Attention to the left (AL)</td></tr><tr><td>P</td><td>G</td><td>P</td><td>G</td><td>P</td><td>G</td></tr><tr><td>Mean</td><td>1.04</td><td>... |
efae721e4dd946bef869c12e7dc23659b64568529fac85fb24667d23635a3ad9.png | complex | <table><tr><td rowspan="2" colspan="2"></td><td colspan="6">Magnetic Detection</td><td colspan="3">Microbiological Tests</td></tr><tr><td colspan="3">Anti-<i>Streptococcus agalactiae</i></td><td colspan="3">Anti-GB Streptococci</td><td colspan="3"></td></tr><tr><td>Mastitic Milk Isolates</td><td></td><td colspan="2">Co... |
9bad03f9ecfb1b697d5f32279abd3634dea053cafa1ecc46839d3544f8105a10.png | simple | <table><tr><td></td><td>NPWT (n = 19)</td><td>Usual care (n = 21)</td><td>Total (n = 40)</td></tr><tr><td>Age (years)*</td><td>58·8(15·1)</td><td>56·9(13·9)</td><td>57·8(14·4)</td></tr><tr><td>Sex ratio (M : F)</td><td>11 : 8</td><td>11 : 10</td><td>22 : 18</td></tr><tr><td>BMI (kg/m<sup>2... |
80679c5830d76b26fb0ff6bfab0c9304f6f48a5d3ebab9d3b30411513dce0e6c.png | complex | <table><tr><td colspan="3">SPACE</td><td colspan="3">ESPACE</td></tr><tr><td>No.</td><td>Gene</td><td>Degree</td><td>No.</td><td>Gene</td><td>Degree</td></tr><tr><td>1</td><td>PRC1</td><td>26</td><td>1</td><td>AURKA</td><td>36</td></tr><tr><td>2</td><td>RRM2</td><td>17</td><td>2</td><td>NKX2-1</td><td>35</td></tr><tr><... |
18ac7c1cf39b0a2c4d031345891d78c74583d0ba46b8acc5234bc9e961fa2c0a.png | complex | <table><tr><td colspan="6">Model description</td></tr><tr><td></td><td>Y</td><td>No. of variables</td><td>No. of observations</td><td colspan="2">Degrees of freedom</td></tr><tr><td></td><td>SMR</td><td>3</td><td>2306</td><td>2303</td><td></td></tr><tr><td colspan="6">Model fit</td></tr><tr><td></td><td>R<sup>2</sup></... |
101cea65750dbe5753ab56fc66ceef2af0078231f88db983e47ef42a8ffbfa37.png | simple | <table><tr><td>Cancer types</td><td>Key message(s)</td><td>Ref.</td></tr><tr><td>Breast cancer</td><td>Dephosphorylation of FOXO3a induced by Aplysin suppresses tumor growth by inhibiting cell proliferation and promoting apoptosis in cancer cells.</td><td>[89]</td></tr><tr><td>Prostate cancer</td><td>Deregulation of FO... |
fdb119dfc9407771df0b1d38118e41a70e4032f97b8e275ebbb5dc4945e75fb0.png | complex | <table><tr><td>Rate of failure in control group (%)</td><td colspan="6">Rate of failure in the intervention group (%)</td></tr><tr><td></td><td colspan="2">10</td><td colspan="2">15</td><td colspan="2">25</td></tr><tr><td></td><td>80% power</td><td>90% power</td><td>80% power</td><td>90% power</td><td>80% power</td><td... |
63c2d6cb17efe648df5a160dec34230b4cadf4e6aa0f2a6ad6e169951ba263e0.png | simple | <table><tr><td>Variables</td><td>Renal cell carcinoma (n = 76)</td></tr><tr><td>Age (mean, years)</td><td>61.3 ± 13.5</td></tr><tr><td>Sex</td><td> </td></tr><tr><td>Male</td><td>45</td></tr><tr><td>Female</td><td>31</td></tr><tr><td>Tumor type</td><td> </td></tr><tr><td>Clear cell</td><td>59</td></tr><tr><td>Papi... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.